{"disease":{"id":"rapid-progressive-interstitial-lung-diseases","name":"rapid progressive interstitial lung diseases"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05181397","title":"The Efficacy and Safety of Tocilizumab for Severe RP-ILD Secondary to Systemic Diseases","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":68,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}